Correlação linear e espsacial entre a produtividade de feijão e a porosidade de um Latossolo Vermelho de Selvíria (MS)

Soil porosity influences plant development since root growth and crop yield are determined by the root depth. The objective of this study was to investigate the linear and spatial variability and correlations between common bean yield and soil porosity. The bean grain yield of the irrigated cultivar Carioca IAC was analyzed in the growing season 2004/2005, in Selviria-MS, as well as macroporosity (MA), microporosity (MI) and total porosity (TP), in a Dystroferric Red Latosol, at four depths: 1 (0.0-0.10 m), 2 (0.10-0.20 M), 3 (0.20-0.30 m) and 4 (0.30-0.40 m). Soil and plant data were collected in a geostatistical grid with 135 points spaced 10 m apart, covering an area of 50 x 150 m. The data of the studied attributes did not vary randomly and the values were intermediate to low. They followed well-defined spatial standards, reaching between 11.70-104.40 m. on the other hand, the linear correlation between the plant and soil attributes was low, due to the high number of observations. Grain yield had the best linear correlations with MA1b, MI1 and TP3. From the spatial point of view, the inverse correlation between PG and #TP2 was outstanding. At the sites where #TP2 diminished (0.030-0.045 m(3) m(-3)) the yield varied from 2,173 to 3,529 kg ha(-1) and where it increased (0.045-0.076 m(3) m(-3)), the yield was between 1,630 and 2,173 kg ha(-1). Therefore, the total soil porosity, evaluated in the 0.10-0.20 m layer (#TP2), indicated the importance of the contact root/soil and was in turn a satisfactory indicator of soil physical quality, with a view to the grain yield of irrigated common bean.

CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis

Background: Urothelial bladder carcinoma (UBC) is a chemo-sensitive tumour, but the response to treatment is heterogeneous. CD 147 has been associated with chemotherapy resistance. We aimed to define tumours with an aggressive phenotype by the combined analysis of clinicopathological and biological parameters.Methods: 77 patients with T1G3 or muscle-invasive UBC treated by radical cystectomy were studied. Immunohistochemistry was performed to detect CD147, heparanase, CD31 (blood vessels identification) and D2-40 (lymphatic vessels identification) expressions. The immunohistochemical reactions were correlated with the clinicopathological and the outcome parameters. 5-year disease-free survival (DFS) and overall survival (OS) rates were estimated using the Kaplan-Meier method. Multivariate analysis was performed by Cox proportional hazards analysis.Results: The 5-year DFS and OS rates were significantly influenced by the classical clinicopathological parameters, and by the occurrence of lymphovascular invasion. CD 147 and heparanase immunoexpression did not affect patients' outcome. However, patients with pT3/pT4 tumours had a median OS time of 14.7 months (95% CI 7.1-22.3, p = 0.003), which was reduced to 9.2 months (95% CI 1.5-17.0, p = 0.008) if the tumours were CD147 positive. We developed a model of tumour aggressiveness using parameters as stage, grade, lymphovascular invasion and CD147 immunoexpression, which separated a low aggressiveness from a high aggressiveness group, remaining as an independent prognostic factor of DFS (HR 3.746; 95% CI 1.244-11.285; p = 0.019) and OS (HR 3.247; 95% CI 1.015-10.388, p = 0.047).Conclusion: CD 147 overexpression, included in a model of UBC aggressiveness, may help surgeons to identify patients who could benefit from a personalized therapeutic regimen. Additional validation is needed. (C) 2011 Elsevier Ltd. All rights reserved.

Análise in vitro da resistência adesiva de resinas compostas em cavidades de classe II, através do teste de microtração. Efeito de diferentes técnicas restauradoras

Pós-graduação em Ciências Odontológicas - FOAR

Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients

Urothelial bladder carcinoma (UBC) is heterogeneous in its pathology and clinical behaviour. Evaluation of prognostic and predictive biomarkers is necessary, in order to produce personalised treatment options. The present study used immunohistochemistry to evaluate UBC sections containing tumour and non-tumour areas from 76 patients, for the detection of p-mTOR, CD31 and D2-40 (blood and lymphatic vessels identification, respectively). Of the non-tumour and tumour sections, 36 and 20% were scored positive for p-mTOR expression, respectively. Immunoexpression was observed in umbrella cells from non-tumour urothelium, in all cell layers from non-muscle-invasive (NMI) tumours (including expression in superficial cells), and in spots of cells from muscle-invasive (MI) tumours. Positive expression decreased from non-tumour to tumour urothelium, and from pTl/pTis to pT3/pT4 tumours; however, the few pT3/pT4 positive cases had worse survival rates, with 5-year disease-free survival being significantly lower. Angiogenesis occurrence was impaired in pT3/pT4 tumours that did not express p-mTOR. In conclusion, p-mTOR expression in non-tumour umbrella cells is likely a reflection of their metabolic plasticity, and extension to the inner layers of the urothelium in NMI tumours is consistent with an enhanced malignant potential. The expression in cell spots in a few MI tumours and absence of expression in the remaining tumours is intriguing and requires further research. Additional studies regarding the up- and downstream effectors of the mTOR pathway should be conducted.